《全日总结》恒指下滑643点 恒生科指跌半成 药明生物挫一成
美债孳息再度上升，美股纳指昨(3日)跌2.7%，加上内地股市跌逾2%，港股今日回落。恒指低开354点後跌幅扩大，曾跌778点一度低见29,102点，午市跌幅收窄，全日跌643点或2.2%，收29,236点；国指跌340点或2.9%，收11,325点；恒生科技指数跌546点或5.8%，收8,819点。大市全日成交总额2,243.54亿元，沪、深港通南下交易录得净流出金额分别为1.39亿及12亿元人民币。
汇控(00005.HK)升0.6%报46.55元，港交所(00388.HK)跌3%报483元，友邦(01299.HK)升0.6%报99.85元，中银香港(02388.HK)获高盛唱好，股价逆升2.5%。中移动(00941.HK)跌2.2%报55元。九龙仓置业(01997.HK)去年基础净盈利减少24%，全日股价跌2.4%。中石油(00857.HK)升1.4%，为升幅最大国指成分股。
科技股捱沽，腾讯(00700.HK)跌4.6%报690元，阿里巴巴(09988.HK)跌2.2%报227.2元。美团(03690.HK)跌8.7%报340元。小米(01810.HK)跌4%报25.4元，京东(09618.HK)及网易(09999.HK)各跌4%及4.4%，快手(01024.HK)跌5.5%报299.6元。
此外，微盟(02013.HK)跌12.8%。心动(02400.HK)及金山软件(03888.HK)各跌11.9%及12.3%，京东健康(06618.HK)、明源云(00909.HK)及众安在线(06060.HK)各跌8.7%至10%。手机相关股比亚迪电子(00285.HK)及舜宇(02382.HK)各跌6.9%及6.8%。晶片相关股ASM太平洋(00522.HK)及华虹半导体(01347.HK)各跌6.9%及9.9%。
内需股亦受压，呷哺呷哺(00520.HK)跌11.8%，海底捞(06862.HK)及统一企业中国(00220.HK)各跌8.1%及6.9%，海尔智家(06690.HK)、国美(00493.HK)、阿里影业(01060.HK)及农夫山泉(09633.HK)各跌4.6%至5%。汽车股比亚迪(01211.HK)及长城汽车(02333.HK)各跌8.1%及8.9%，吉利(00175.HK)跌5.7%。
医药股方面，药明生物(02269.HK)Vir研发新冠中和抗体临床三期失败，全日股价挫10.2%收92元，为跌幅最大蓝筹。信达生物(01801.HK)跌6.3%，绿叶制药(02186.HK)及复星医药(02196.HK)各跌4.7%及4.4%。
资源及金属股向下，紫金(02899.HK)跌13%，赣锋锂业(01772.HK)及江铜(00358.HK)各跌9%及8.8%，五矿资源(01208.HK)及洛钼(03993.HK)各跌5%及6.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
